Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early everolimus introduction with calcineurin inhibitor withdrawal after kidney transplantation
2006-000269-12Phase 4Terminated
- Sponsor
- Sociedad Madrileña de Nefrología
- Start
- Jul 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in kidney transplant comparing Everolimus with calcineurin inhibitor withdrawal with Tacrolimus maintenance control (2 arms). Primary endpoint: Renal function at month 15 post-transplant. Started Jul 2006; status: terminated.
02
Drugs
everolimustacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2006-000269-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000269-12.